Summary
This prediction ended on 19.04.16 with a price of €107.60. With a performance of 8.48%, the BUY prediction by Sandokan for Bayer AG closed with a slight gain. Sandokan has a follow-up prediction for Bayer AG where he still thinks Bayer AG is a Buy. Sandokan has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 4.838% | 4.838% | -50.663% | -47.357% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by Sandokan for this prediction
In the thread Bayer AG diskutieren
BAYER kaufen
BAYER Kaufen
Bald kommt wieder die Dividendensaison,
da denke ich steigen viele vorher in Bayer ein
und wollen die Dividende kassieren,
deshalb dürfte die Aktie etwas steigen die nächsten Wochen
und somit mir etwas Profit bringen.